Tacrolimus (MedinCell)

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameTacrolimus (MedinCell)
Drug Alias Namemdc-GRTTacrolimus (MedinCell)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcineurin inhibitors
TargetsCalcineurin
Therapy Area/IndicationsRejection of organ transplantationGraft vs Host DiseaseMyeloproliferative Disorders +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedincell SA
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer InstituteNorthside Hospital IncThe University Of Texas MD Anderson Cancer Center
Inactive CompaniesMedincell SA
Active IndicationsGraft vs Host DiseaseMyeloproliferative DisordersMyelodysplastic Syndromes +[8] 
Inactive IndicationsRejection of organ transplantation

Other Information

ATC CodeN/A
Related LinksN/A